Date:18/02/2006 URL: http://www.thehindubusinessline.com/2006/02/18/stories/2006021803190200.htm

Back Dr Reddy's acquisition includes research centre

Our Bureau

Hyderabad , Feb 17

THE big-ticket acquisition of Betapharm Arzneimittel, Germany by Dr Reddy's Laboratories for 480 million euros (around Rs 2,250 crore) also includes a not-for profit beta institute.

Founded in 1999, the beta institute focuses on applied health management. Its core services are focused on social-medical research, advanced training, consulting, project development, and information services.

For the research-driven Dr Reddy's Laboratories, the institute's strength to independently develop and prove innovative concepts in practice would be an added advantage.

According to a release from 3i, Europe's leading private equity and venture capital company, which sold Betapharm to Dr Reddy's, the beta institute works closely and evaluate these concepts with Universities.

Over the years, this approach has helped Betapharm bring several innovative solutions for today's healthcare system.